Silvercrest Asset Management Group LLC Johnson & Johnson Transaction History

Silvercrest Asset Management Group LLC

$14.1 Billion
Q1 2024

A detailed history of Silvercrest Asset Management Group LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 572,730 shares of JNJ stock, worth $83.7 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

572,730

Previous 574,825 0.36%

Holding current value

$83.7 Million

Previous $90.1 Million 0.56%

% of portfolio

0.64%

Previous 0.65%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $325,185 - $340,940	-2,095 Reduced 0.36%	572,730 $90.6 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $2.07 Million - $2.26 Million	-14,235 Reduced 2.42%	574,825 $90.1 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $2.31 Million - $2.58 Million	-14,815 Reduced 2.45%	589,060 $91.7 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $2.16 Million - $2.32 Million	-13,993 Reduced 2.26%	603,875 $100 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $1.53 Million - $1.83 Million	-10,159 Reduced 1.62%	617,868 $95.8 Million

Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $870,366 - $976,799	-5,433 Reduced 0.86%	628,027 $111 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $619,991 - $689,895	-3,843 Reduced 0.6%	633,460 $103 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $3 Million - $3.32 Million	17,853 Added 2.88%	637,303 $113 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $541,787 - $615,275	-3,426 Reduced 0.55%	619,450 $110 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $152,031 - $168,684	-975 Reduced 0.16%	622,876 $107 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $3.48 Million - $3.87 Million	-21,554 Reduced 3.34%	623,851 $101 Million
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $196,479 - $210,758	-1,232 Reduced 0.19%	645,405 $106 Million
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $1.31 Million - $1.46 Million	-8,569 Reduced 1.31%	646,637 $106 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $464,665 - $533,360	-3,389 Reduced 0.51%	655,206 $103 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $1.19 Million - $1.3 Million	-8,479 Reduced 1.27%	658,595 $98.1 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $693,126 - $836,799	5,381 Added 0.81%	667,074 $93.8 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $1.06 Million - $1.48 Million	-9,581 Reduced 1.43%	661,693 $86.8 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $21,420 - $24,601	168 Added 0.03%	671,274 $97.9 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $1.99 Million - $2.23 Million	-15,666 Reduced 2.28%	671,106 $86.8 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $1.1 Million - $1.21 Million	8,389 Added 1.24%	686,772 $95.7 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $149,732 - $166,489	1,191 Added 0.18%	678,383 $94.8 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $2 Million - $2.41 Million	-16,305 Reduced 2.35%	677,192 $87.4 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $431,852 - $507,509	-3,552 Reduced 0.51%	693,497 $95.8 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $508,047 - $560,638	-4,255 Reduced 0.61%	697,049 $84.6 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $355,659 - $421,162	2,843 Added 0.41%	701,304 $89.9 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $189,744 - $207,674	1,446 Added 0.21%	698,461 $97.6 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $90.2 Million - $94.4 Million	697,015	697,015 $90.6 Million

Others Institutions Holding JNJ

# of Institutions

4,145

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $382B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.

Account

Silvercrest Asset Management Group LLC Johnson & Johnson Transaction History